Application of GQSAR for Scaffold Hopping and Lead Optimization in Multitarget Inhibitors

被引:18
作者
Ajmani, Subhash [1 ]
Kulkarni, Sudhir A. [1 ,2 ]
机构
[1] NovaLead Pharma Pvt Ltd, Pride Purple Coronet, Pune 411045, Maharashtra, India
[2] VLife Sci Technol Pvt Ltd, Pride Purple Coronet, Pune 411045, Maharashtra, India
关键词
Group based QSAR; Scaffold hopping; Lead optimization; Multitarget inhibitors; DESIGNING MULTIPLE LIGANDS; PROTEIN-KINASE INHIBITORS; DRUG DISCOVERY; NETWORK PERSPECTIVES; REUPTAKE INHIBITORS; QSPR MODELS; MECHANISMS; DATABASE; QSAR; ANTIDEPRESSANTS;
D O I
10.1002/minf.201100160
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Many literature reports suggest that drugs against multiple targets may overcome many limitations of single targets and achieve a more effective and safer control of the disease. However, design of multitarget drugs presents a great challenge. The present study demonstrates application of a novel Group based QSAR (GQSAR) method to assist in lead optimization of multikinase (PDGFR-beta, FGFR-1 and SRC) and scaffold hopping of multiserotonin target (serotonin receptor 1A and serotonin transporter) inhibitors. For GQSAR analysis, a wide variety of structurally diverse multikinase inhibitors (225 molecules) and multiserotonin target inhibitors (162 molecules) were collected from various literature reports. Each molecule in the data set was divided into four fragments (kinase inhibitors) and three fragments (serotonin target inhibitors) and their corresponding two-dimensional fragment descriptors were calculated. The multiresponse regression GQSAR models were developed for both the datasets. The developed GQSAR models were found to be useful for scaffold hopping and lead optimization of multitarget inhibitors. In addition, the developed GQSAR models provide important fragment based features that can form the building blocks to guide combinatorial library design in the search for optimally potent multitarget inhibitors.
引用
收藏
页码:473 / 490
页数:18
相关论文
共 50 条
  • [21] Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements
    Iusupov, Ildar R.
    Curreli, Francesca
    Spiridonov, Evgeniy A.
    Markov, Pavel O.
    Ahmed, Shahad
    Belov, Dmitry S.
    Manasova, Ekaterina, V
    Altieri, Andrea
    Kurkin, Alexander, V
    Debnath, Asim K.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 224
  • [22] ADMETopt: A Web Server for ADMET Optimization in Drug Design via Scaffold Hopping
    Yang, Hongbin
    Sun, Lixia
    Wang, Zhuang
    Li, Weihua
    Liu, Guixia
    Tang, Yun
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2018, 58 (10) : 2051 - 2056
  • [23] Identification of novel PI3K inhibitors through a scaffold hopping strategy
    Martinez Gonzalez, Sonia
    Isabel Hernandez, Ana
    Maria Alvarez, Rosa
    Rodriguez, Antonio
    Ramos-Lima, Francisco
    Bischoff, James R.
    Isabel Albarran, Maria
    Cebria, Antonio
    Hernandez-Encinas, Elena
    Garcia-Arocha, Jennifer
    Cebrian, David
    Blanco-Aparicio, Carmen
    Pastor, Joaquin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (21) : 4794 - 4799
  • [24] A Scaffold-Hopping Strategy toward the Identification of Inhibitors of Cyclin G Associated Kinase
    Wouters, Randy
    Tian, Junjun
    Herdewijn, Piet
    De Jonghe, Steven
    CHEMMEDCHEM, 2019, 14 (02) : 237 - 254
  • [25] Discovery of novel CDK inhibitors via scaffold hopping from CAN508
    Jing, Liandong
    Tang, Yanbo
    Xiao, Zhiyan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (08) : 1386 - 1391
  • [26] Strategies for the generation, validation and application of in silico ADMET models in lead generation and optimization
    Gleeson, Matthew Paul
    Montanari, Dino
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (11) : 1435 - 1446
  • [27] Discovery of Pyridyl-Benzothiazol Hybrids as Novel Protoporphyrinogen Oxidase Inhibitors via Scaffold Hopping
    Cai, Hui
    Zhang, Xiao
    Ling, Dan
    Zhang, Meng
    Pang, Chen
    Chen, Zhongyin
    Jin, Zhichao
    Ren, Shi-Chao
    Chi, Yonggui Robin
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2024, 72 (16) : 8963 - 8972
  • [28] Structure-Based Discovery of New Succinate Dehydrogenase Inhibitors via Scaffold Hopping Strategy
    Huang, Yuan-Hui
    Wei, Ge
    Wang, Wen-Jie
    Liu, Zheng
    Yin, Mao-Xue
    Guo, Wei-Min
    Zhu, Xiao-Lei
    Yang, Guang-Fu
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (47) : 18292 - 18300
  • [29] Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold-Hopping Approach
    Tan, Kathrin
    Jaeger, Christian
    Koerschgen, Hagen
    Geissler, Stefanie
    Schlenzig, Dagmar
    Buchholz, Mirko
    Stoecker, Walter
    Ramsbeck, Daniel
    CHEMMEDCHEM, 2021, 16 (06) : 976 - 988
  • [30] Scaffold Hopping-Driven Optimization of 4-(Quinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-ones as Novel Tubulin Inhibitors
    Jiang, Li
    Goto, Masuo
    Zhu, Dong-Qing
    Hsu, Pei-Ling
    Li, Kang-Po
    Cui, Mutian
    He, Xiaoyang
    Morris-Natschke, Susan Lynne
    Lee, Kuo-Hsiung
    Xie, Lan
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (01): : 83 - 89